Page last updated: 2024-09-03

1,3-di(4-imidazolinophenoxyl)propane and artenimol

1,3-di(4-imidazolinophenoxyl)propane has been researched along with artenimol in 1 studies

Compound Research Comparison

Studies
(1,3-di(4-imidazolinophenoxyl)propane)
Trials
(1,3-di(4-imidazolinophenoxyl)propane)
Recent Studies (post-2010)
(1,3-di(4-imidazolinophenoxyl)propane)
Studies
(artenimol)
Trials
(artenimol)
Recent Studies (post-2010) (artenimol)
12081,419279987

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y1

Other Studies

1 other study(ies) available for 1,3-di(4-imidazolinophenoxyl)propane and artenimol

ArticleYear
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Jul-01, Volume: 105, Issue:26

    Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2008